The Patent Finder
TH

Theravance, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

74 patents currently held

20 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in Nov 2026. from the record

Of the 20 now held by other companies, 14 name Eonhf Inc. as their current owner, and 6 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
44
Ending by 2030
Nov 2026
Next term end
45
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 16 to 19, 2026 · next Nov 16
  • 2 fees due Dec 2 to 4, 2026 · next Dec 2
  • 2 fees due Jan 4 to 18, 2027 · next Jan 4
  • 2 fees due Feb 15 to 28, 2027 · next Feb 15
  • 1 fee due Mar 22, 2027
    The maintenance fee for Crystalline Form of a Substituted Thiazolylacetic Acid Triethylamine Salt (US 9,139,542) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
  • 3 fees due Apr 20 to 24, 2027 · next Apr 20
  • 1 fee due May 14, 2027
    The maintenance fee for Pyrimidine Compound as Jak Kinase Inhibitor (US 11,814,377) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Crystalline Freebase Forms of a Biphenyl Compound (US 11,858,898) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 2 fees due Aug 4 to 18, 2027 · next Aug 4

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 17, 2026

What they patent

The 5 largest of its 45 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 7,329,752Carbamate Compounds as 5-HT4 Receptor Agonists
In force
 · High confidence
In forceHigh confidence
US 8,377,965Crystalline Forms of a Biphenyl Compound
In force
 · Medium confidence
In forceMedium confidence
US 7,479,562Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
In force
 · High confidence
In forceHigh confidence
US 7,446,114Quinolinone Compounds as 5-HT4 Receptor Agonists
In force
 · High confidence
In forceHigh confidence
US 8,242,137Crystalline Forms of a Biphenyl Compound
In force
 · Low confidence
In forceLow confidence
US 7,528,253Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
In force
 · High confidence
In forceHigh confidence
US 7,569,586Compounds Having Beta Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
In force
 · High confidence
In forceHigh confidence
US 7,566,785Amidine Substituted Aryl Aniline Compounds
In force
 · High confidence
In forceHigh confidence
US 7,560,469Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
In force
 · Medium confidence
In forceMedium confidence
US 7,569,588Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
In force
 · Medium confidence
In forceMedium confidence
10 of 74 patents shown.
Pro members see all 74.
Pro members: see all 74 patents
Also on record, not counted in the 74: 20 patents in force now held by others · 158 patents ended · 5 applications pending · 21 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited